The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2
about
Differences in interferon alpha and beta signaling. Interferon beta selectively induces the interaction of the alpha and betaL subunits of the type I interferon receptorEngagement of Gab1 and Gab2 in erythropoietin signalingEngagement of the CrkL adaptor in interferon alpha signalling in BCR-ABL-expressing cellsErythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2. An alternate pathway for erythropoietin-induced phosphatidylinositol 3-kinase activationThe type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor proteinGrowth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signalingIdentification of the rat adapter Grb14 as an inhibitor of insulin actionsActivation of a CrkL-stat5 signaling complex by type I interferons.Interferon type I signaling pathwaysImmunological approach to hepatocellular carcinoma.The role of glycogen synthase kinase 3 in regulating IFN-β-mediated IL-10 production.Suppression of interferon (IFN)-inducible genes and IFN-mediated functional responses in BCR-ABL-expressing cells.A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype.Interferon-α in acute myeloid leukemia: an old drug revisited.Current understanding of insulin resistance in hepatitis C.Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells.mTOR, metabolism, and the regulation of T-cell differentiation and function.Protein kinase C-delta (PKC-delta ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727.Activation of the p38 mitogen-activated protein kinase by type I interferons.IFNs-signaling effects on lung cancer: an up-to-date pathways-specific review.Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy.Enhanced suppressor of cytokine signaling 3 in arthritic cartilage dysregulates human chondrocyte function.Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion.Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons.Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cellsEngagement of protein kinase C-theta in interferon signaling in T-cells.Insulin receptor substrate-2-dependent interleukin-4 signaling in macrophages is impaired in two models of type 2 diabetes mellitus.Interferon alpha-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathway.Role of p38alpha Map kinase in Type I interferon signaling.Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons.Interferon alpha activates the tyrosine kinase Lyn in haemopoietic cells.Identification of a domain in the beta subunit of the type I interferon (IFN) receptor that exhibits a negative regulatory effect in the growth inhibitory action of type I IFNs.Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling.The pleckstrin homology domain is the principal link between the insulin receptor and IRS-1.Innate immunity in pluripotent human cells: attenuated response to interferon-β.Eradicating hepatitis C virus ameliorates insulin resistance without change in adipose depots.Phosphatidylinositol 3'-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase.Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis.A PI-3 kinase-dependent, Stat1-independent signaling pathway regulates interferon-stimulated monocyte adhesion.Activation of mitogen-activated protein kinase kinase (MKK) 3 and MKK6 by type I interferons.
P2860
Q24321932-F154DD4A-C657-43E3-B917-C62F1DADE9DEQ28142601-F3ACC7CE-8467-43BB-9588-7B2786DE22FBQ28199681-53F14301-FD46-49E5-A45A-2DDDCDCEE4CAQ28251507-2CEE1B99-FDDB-45C7-98AE-C0558BB5B922Q28255013-A4064D70-79CD-40EE-B9B7-9142D05A1E21Q28296345-114C72CB-390F-4E07-928E-B38453CC3B9CQ28565588-695DD2F1-66A3-4482-863E-F8B8594C1D64Q30175923-497C4618-252E-4796-A181-8498C2740145Q30230895-6FC8570E-8BF2-4DF7-B989-B7B73B1ECA92Q32147095-A55A9224-9E96-4692-8191-10DAA4751935Q36712311-F747048E-DCF0-4A33-8652-43C37BC4652FQ36749168-945B1656-38F9-45AD-9A90-B342B6CD6F4CQ37361198-6F0DD042-C852-4CC0-9941-87A5DFBD1203Q37832939-EE262861-50AB-44C5-A7F9-660BBCF0D9A6Q37903853-02B947B6-3F22-4C86-8C6E-9BE502EC6158Q38007403-FEEFAD10-971D-43C7-928D-F75EA9137059Q38034265-8F30C6C3-41CA-449F-BC50-F042241B9B62Q38292168-77A0C73B-1E7D-44FC-9C13-F75444200751Q38319686-9A8EB580-04FD-485E-AA8F-5F749F66DAE5Q38758152-EF4EDF83-BAD4-4586-AA59-21F575F0AFC1Q39109430-6C17F9BA-0F0E-4D71-A190-6F6E332B5DD9Q39350274-C451628D-A324-4A60-8B54-7DF1B7B93637Q39460470-DD894002-2A2B-431B-ADB9-11069C5B5E11Q40020509-879361B3-C10E-4DC3-ACF7-8684C9D43C65Q40435523-C9882700-AB01-434D-A61B-1B1C86D26D13Q40554296-B71B2502-7C0F-41BE-A387-5C83A1865E06Q40559827-FB21F1FA-7D86-453D-9CFC-AFCE15208CD1Q40571407-A824AE05-27BB-4C0D-898E-3EC50B9162F9Q40623106-B96B0D2B-EFE3-4B58-B32B-A13C57E22F4AQ40646200-C17776C1-1691-4936-8735-0254909EFC2DQ41032505-CB28C7A6-6AB0-4863-A2BB-4DF8B4B70624Q41052398-951F318C-9F1B-4676-AC28-580E00360FC3Q41127803-64B59ED9-900A-4007-A337-F6B844210690Q41166090-7EE3DD5D-06AF-4B2A-87F6-373E3A06A0BFQ41282268-64B7907F-B520-4125-8498-A8EDD0AF3099Q42225921-3D0CF8EE-3E51-4B78-B829-B220EC0A2DA8Q42991883-807680BA-B726-48EC-B387-60DC3A81613AQ43843414-7AACEC88-F873-4A1B-8841-6EEAD1809E29Q44378771-5E7A53ED-5019-4825-B995-12403EE9B129Q45219850-DE9CAABE-9CD5-437B-9192-FB56F0BEA950
P2860
The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
The type I interferon receptor ...... f insulin receptor substrate 2
@ast
The type I interferon receptor ...... f insulin receptor substrate 2
@en
The type I interferon receptor ...... f insulin receptor substrate 2
@nl
type
label
The type I interferon receptor ...... f insulin receptor substrate 2
@ast
The type I interferon receptor ...... f insulin receptor substrate 2
@en
The type I interferon receptor ...... f insulin receptor substrate 2
@nl
prefLabel
The type I interferon receptor ...... f insulin receptor substrate 2
@ast
The type I interferon receptor ...... f insulin receptor substrate 2
@en
The type I interferon receptor ...... f insulin receptor substrate 2
@nl
P2093
P2860
P356
P1476
The type I interferon receptor ...... f insulin receptor substrate 2
@en
P2093
P2860
P304
P356
10.1074/JBC.271.1.278
P407
P50
P577
1996-01-01T00:00:00Z